Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency

  • Muñoz López, Álvaro|||0000-0002-4601-5633
  • Romero Moya, Damià|||0000-0001-9947-3577
  • Prieto, Cristina|||0000-0002-0812-8100
  • Ramos Mejía, Verónica
  • Agraz-Doblás, Antonio|||0000-0003-1307-4175
  • Varela, Ignacio|||0000-0002-0969-506X
  • Buschbeck, Marcus|||0000-0002-3218-4567
  • Palau de Miguel, Anna|||0000-0003-2131-1265
  • Carvajal Vergara, Xonia
  • Giorgetti, Alessandra|||0000-0001-5803-3567
  • Ford, Anthony
  • Lako, Majlinda
  • Granada, Isabel|||0000-0002-4275-0104
  • Ruiz Xivillé, Neus
  • Rodríguez Perales, Sandra
  • Torres Ruíz, Raúl
  • Stam, Ronald W.
  • Fuster, José Luis|||0000-0002-4881-9440
  • Fraga, Mario|||0000-0001-8450-2603
  • Nakanishi, Mahito
  • Cazzaniga, Giovanni|||0000-0003-2955-4528
  • Bardini, Michela|||0000-0002-6942-2274
  • Cobo, Isabel
  • Fernández Bayón, Gustavo|||0000-0002-0763-0473
  • Fernández, Agustín F.|||0000-0002-3792-4085
  • Bueno, Clara|||0000-0003-1442-6216
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple cell types at different developmental stages. However, reprogramming leukemias is an extremely inefficient process. Few studies generated iPSCs from primary chronic myeloid leukemias, but iPSC generation from acute myeloid or lymphoid leukemias (ALL) has not been achieved. We attempted to generate iPSCs from different subtypes of B-ALL to address the developmental impact of leukemic fusion genes. OKSM(L)-expressing mono/polycistronic-, retroviral/lentiviral/episomal-, and Sendai virus vector-based reprogramming strategies failed to render iPSCs in vitro and in vivo. Addition of transcriptomic-epigenetic reprogramming "boosters" also failed to generate iPSCs from B cell blasts and B-ALL lines, and when iPSCs emerged they lacked leukemic fusion genes, demonstrating non-leukemic myeloid origin. Conversely, MLL-AF4-overexpressing hematopoietic stem cells/B progenitors were successfully reprogrammed, indicating that B cell origin and leukemic fusion gene were not reprogramming barriers. Global transcriptome/DNA methylome profiling suggested a developmental/differentiation refractoriness of MLL-rearranged B-ALL to reprogramming into pluripotency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

  • Díaz de la Guardia, Rafael|||0000-0001-9568-6719
  • López-Millán, Belén|||0000-0002-9757-5454
  • Lavoie, Jessie R.
  • Bueno, Clara|||0000-0003-1442-6216
  • Castaño Cardoso, Julio|||0000-0002-0712-5856
  • Gómez-Casares, Maite
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • Juan, Manel|||0000-0002-3064-1648
  • Delgado, Julio|||0000-0002-5157-4376
  • Blanco, Maria L.
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Chaparro, Alberto
  • Fuster, José Luis|||0000-0002-4881-9440
  • Anguita, Eduardo|||0000-0003-1386-4943
  • Rosu-Myles, Michael
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Bone marrow mesenchymal stem/stromal cells (BM-MSCs) are key components of the hematopoietic niche thought to have a direct role in leukemia pathogenesis. BM-MSCs from patients with acute myeloid leukemia (AML) have been poorly characterized due to disease heterogeneity. We report a functional, genetic, and immunological characterization of BM-MSC cultures from 46 AML patients, stratified by molecular/cytogenetics into low-risk (LR), intermediate-risk (IR), and high-risk (HR) subgroups. Stable MSC cultures were successfully established and characterized from 40 of 46 AML patients irrespective of the risk subgroup. AML-derived BM-MSCs never harbored tumor-specific cytogenetic/molecular alterations present in blasts, but displayed higher clonogenic potential than healthy donor (HD)-derived BM-MSCs. Although HD- and AML-derived BM-MSCs equally provided chemoprotection to AML cells in vitro, AML-derived BM-MSCs were more immunosuppressive/anti-inflammatory, enhanced suppression of lymphocyte proliferation, and diminished secretion of pro-inflammatory cytokines. Multivariate analysis revealed that the level of interleukin-10 produced by AML-derived BM-MSCs as an independent prognostic factor negatively affected overall survival. Collectively our data show that AML-derived BM-MSCs are not tumor related, but display functional differences contributing to therapy resistance and disease evolution. In this article, Díaz de la Guardia and colleagues report a functional, genetic, and immunological characterization of BM-MSC cultures from 46 AML patients, stratified by molecular/cytogenetics into low-risk (LR), intermediate-risk (IR), and high-risk (HR) subgroups. BM-MSCs never harbored tumor-specific cytogenetic/molecular alterations present in blasts, and IL-10 produced by AML-derived BM-MSCs is an independent prognostic factor negatively impacting on overall survival.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

  • Urdinguio, Rocío G.|||0000-0003-2736-5758
  • López, Virginia|||0000-0002-0065-7999
  • Fernández Bayón, Gustavo|||0000-0002-0763-0473
  • Díaz de la Guardia, Rafael|||0000-0001-9568-6719
  • Sierra, Marta I.
  • García-Toraño, Estela
  • Pérez, Raúl F.|||0000-0003-4336-9898
  • García, María G.
  • Carella, Antonella
  • Pruneda, Patricia C.
  • Prieto, Cristina|||0000-0002-0812-8100
  • Dmitrijeva, Marija
  • Santamarina-Ojeda, Pablo|||0000-0002-7439-8467
  • Belmonte, Thalia|||0000-0003-1241-6073
  • Mangas, Cristina
  • Diaconu, Elena|||0000-0002-2115-4311
  • Ferrero, Cecilia
  • Tejedor, Juan Ramón|||0000-0002-4061-9698
  • Fernandez-Morera, Juan Luis|||0000-0003-1244-068X
  • Bravo, Cristina
  • Bueno, Clara|||0000-0003-1442-6216
  • Sanjuan-Pla, Alejandra
  • Rodríguez López, Ramón María|||0000-0002-6770-5123
  • Suárez-Álvarez, Beatriz|||0000-0002-3431-4206
  • López-Larrea, Carlos
  • Bernal, Teresa|||0000-0002-2338-513X
  • Colado, Enrique|||0000-0001-8675-8207
  • Balbín, Milagros|||0000-0001-5325-0407
  • García-Suarez, Olivia
  • Chiara, María Dolores|||0000-0002-1112-1583
  • Sáenz De Santa María, Inés|||0000-0002-1868-3001
  • Rodríguez, Francisco|||0000-0001-7909-932X
  • Pando-Sandoval, Ana|||0000-0002-7923-9107
  • Rodrigo-Sáez, Luis|||0000-0003-1717-9345
  • Santos, Laura|||0000-0002-6194-0683
  • Salas, Ana
  • Vallejo-Díaz, Jesús
  • Carrera, Ana C.
  • Rico, Daniel|||0000-0002-6561-2310
  • Hernández-López, Inmaculada
  • Vayá, Amparo
  • Ricart, José María
  • Seto, Edward
  • Sima, Núria|||0000-0003-4097-1402
  • Vaquero, Alejandro|||0000-0002-8735-4156
  • Valledor, Luís|||0000-0002-0636-365X
  • Cañal Villanueva, María Jesús Fátima|||0000-0002-1639-9672
  • Pisano, David|||0000-0002-4895-4124
  • Graña-Castro, Osvaldo
  • Thomas, Tim|||0000-0002-7623-8344
  • Voss, Anne Kathrin|||0000-0002-3853-9381
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Villar-Garea, Ana|||0000-0001-8960-1635
  • Deutzmann, Rainer
  • Fernández, Agustín F.|||0000-0002-3792-4085
  • Fraga, Mario|||0000-0001-8450-2603
Histone H4 acetylation at Lysine 16 (H4K16ac) is a key epigenetic mark involved in gene regulation, DNA repair and chromatin remodeling, and though it is known to be essential for embryonic development, its role during adult life is still poorly understood. Here we show that this lysine is massively hyperacetylated in peripheral neutrophils. Genome-wide mapping of H4K16ac in terminally differentiated blood cells, along with functional experiments, supported a role for this histone post-translational modification in the regulation of cell differentiation and apoptosis in the hematopoietic system. Furthermore, in neutrophils, H4K16ac was enriched at specific DNA repeats. These DNA regions presented an accessible chromatin conformation and were associated with the cleavage sites that generate the 50 kb DNA fragments during the first stages of programmed cell death. Our results thus suggest that H4K16ac plays a dual role in myeloid cells as it not only regulates differentiation and apoptosis, but it also exhibits a non-canonical structural role in poising chromatin for cleavage at an early stage of neutrophil cell death.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CD133-directed CAR T-cells for MLL leukemia, on-target, off-tumor myeloablative toxicity

  • Bueno, Clara|||0000-0003-1442-6216
  • Velasco-Hernández, Talia|||0000-0003-2183-7443
  • Gutiérrez-Agüera, Francisco|||0000-0002-8620-2839
  • Zanetti, S. R.|||0000-0002-9052-8751
  • Baroni, Matteo Libero|||0000-0001-8265-2050
  • Sánchez Martínez, Diego|||0000-0003-4605-5325
  • Molina, Oscar|||0000-0001-7585-4519
  • Closa, Adria|||0000-0002-9302-337X
  • Agraz-Doblás, Antonio|||0000-0003-1307-4175
  • Marin, Pedro
  • Eyras, Eduardo|||0000-0003-0793-6218
  • Varela, Ignacio|||0000-0002-0969-506X
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis

  • Agraz-Doblás, Antonio|||0000-0003-1307-4175
  • Bueno, Clara|||0000-0003-1442-6216
  • Rogers, R. B.
  • Roy, A.
  • Schneider, P.
  • Bardini, Michela|||0000-0002-6942-2274
  • Ballerini, Paola
  • Cazzaniga, Giovanni|||0000-0003-2955-4528
  • Moreno, T.
  • Revilla, C.
  • Gut, Marta|||0000-0002-4063-7159
  • Valsecchi, M. G.
  • Roberts, I.
  • Pieters, R.
  • De Lorenzo, P.
  • Varela, Ignacio|||0000-0002-0969-506X
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Stam, R. W.
Bcell acute lymphoblastic leukemia is the commonest childhood cancer. In infants, B-cell acute lymphoblastic leukemia remains fatal, especially in patients with t(4;11), present in ~80% of cases. The pathogenesis of t(4;11)/KMT2A-AFF1 (MLL-AF4) infant B-cell acute lymphoblastic leukemia remains difficult to model, and the pathogenic contribution in cancer of the reciprocal fusions resulting from derivative translocated-chromosomes remains obscure. Here, "multi-layered" genome-wide analyses and validation were performed on a total of 124 de novo cases of infant B-cell acute lymphoblastic leukemia uniformly diagnosed and treated according to the Interfant 99/06 protocol. These patients showed the most silent mutational landscape reported so far for any sequenced pediatric cancer. Recurrent mutations were exclusively found in K-RAS and N-RAS, were subclonal and were frequently lost at relapse, despite a larger number of non-recurrent/non-silent mutations. Unlike non-MLL-rearranged B-cell acute lymphoblastic leukemias, B-cell receptor repertoire analysis revealed minor, non-expanded B-cell clones in t(4;11) infant B-cell acute lymphoblastic leukemia, and RNAsequencing showed transcriptomic similarities between t(4;11) infant B-cell acute lymphoblastic leukemias and the most immature human fetal liver hematopoietic stem and progenitor cells, confirming a "pre-VDJ" fetal cellular origin for both t(4;11) and RAS. The reciprocal fusion AF4-MLL was expressed in only 45% (19/43) of the t(4;11) patients, and HOXA cluster genes are exclusively expressed in AF4-MLL-expressing patients. Importantly, AF4-MLL/HOXA-expressing patients had a significantly better 4-year eventfree survival (62.4% vs. 11.7%, P=0.001), and overall survival (73.7 vs. 25.2%, P=0.016). AF4-MLL expression retained its prognostic significance when analyzed in a Cox model adjusting for risk stratification according to the Interfant-06 protocol based on age at diagnosis, white blood cell count and response to prednisone. This study has clinical implications for disease outcome and diagnostic risk-stratification of t(4;11) infant B-cell acute lymphoblastic leukemia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm

  • Castaño Cardoso, Julio|||0000-0002-0712-5856
  • Aranda, Sergi|||0000-0003-3853-430X
  • Bueno, Clara|||0000-0003-1442-6216
  • Calero-Nieto, Fernando|||0000-0003-3358-8253
  • Mejia-Ramirez, Eva|||0000-0003-1251-5223
  • Mosquera, José Luis|||0000-0002-7852-4993
  • Blanco, Enrique|||0000-0001-6261-7370
  • Wang, Xiaonan|||0000-0003-3759-778X
  • Prieto, Cristina|||0000-0002-0812-8100
  • Zabaleta, Lorea
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Rovira, Meritxell|||0000-0002-0538-4846
  • Jiménez-Delgado, Senda
  • Matson, Daniel Rusch|||0000-0003-1430-3128
  • Heyn, Holger|||0000-0002-3276-1889
  • Bresnick, Emery H.
  • Göttgens, Berthold|||0000-0001-6302-5705
  • Di Croce, Luciano|||0000-0003-3488-6228
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Raya, Ángel|||0000-0003-2189-9775
  • Giorgetti, Alessandra|||0000-0001-5803-3567
In vertebrates, GATA2 is a master regulator of hematopoiesis and is expressed throughout embryo development and in adult life. Although the essential role of GATA2 in mouse hematopoiesis is well established, its involvement during early human hematopoietic development is not clear. By combining time-controlled overexpression of GATA2 with genetic knockout experiments, we found that GATA2, at the mesoderm specification stage, promotes the generation of hemogenic endothelial progenitors and their further differentiation to hematopoietic progenitor cells, and negatively regulates cardiac differentiation. Surprisingly, genome-wide transcriptional and chromatin immunoprecipitation analysis showed that GATA2 bound to regulatory regions, and repressed the expression of cardiac development-related genes. Moreover, genes important for hematopoietic differentiation were upregulated by GATA2 in a mostly indirect manner. Collectively, our data reveal a hitherto unrecognized role of GATA2 as a repressor of cardiac fates, and highlight the importance of coordinating the specification and repression of alternative cell fates.